Short Interest in Rewalk Robotics Ltd (RWLK) Increases By 44.8%

Rewalk Robotics Ltd (NASDAQ:RWLK) saw a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 4,467,308 shares, a growth of 44.8% from the January 31st total of 3,085,575 shares. Currently, 9.7% of the company’s shares are short sold. Based on an average daily trading volume, of 8,610,546 shares, the days-to-cover ratio is currently 0.5 days.

A hedge fund recently bought a new stake in Rewalk Robotics stock. Geode Capital Management LLC acquired a new position in Rewalk Robotics Ltd (NASDAQ:RWLK) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 284,311 shares of the medical device company’s stock, valued at approximately $49,000. Geode Capital Management LLC owned 0.79% of Rewalk Robotics as of its most recent filing with the Securities & Exchange Commission. 2.78% of the stock is currently owned by institutional investors and hedge funds.

Shares of NASDAQ RWLK opened at $0.26 on Friday. Rewalk Robotics has a 1 year low of $0.16 and a 1 year high of $1.35. The company has a debt-to-equity ratio of 3.59, a quick ratio of 2.04 and a current ratio of 2.46. The stock has a market cap of $19.40 million, a P/E ratio of -0.44 and a beta of 1.88.

Rewalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings results on Friday, February 8th. The medical device company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.04. Rewalk Robotics had a negative net margin of 331.18% and a negative return on equity of 3,654.32%. The company had revenue of $1.58 million for the quarter.

Separately, ValuEngine upgraded shares of Rewalk Robotics from a “hold” rating to a “buy” rating in a research report on Monday, February 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $1.56.

ILLEGAL ACTIVITY NOTICE: This news story was reported by Fairfield Current and is owned by of Fairfield Current. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.fairfieldcurrent.com/news/2019/03/03/short-interest-in-rewalk-robotics-ltd-rwlk-increases-by-44-8.html.

About Rewalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

Recommended Story: What are retained earnings?

Receive News & Ratings for Rewalk Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Rewalk Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.